FindTrial
Sign In

To establish the correlation between level of serum NT PRO BNP and the severity of congenital heart disease in children

To establish the correlation between the level of serum NT-PRO Brain Natriuretic Peptide and severity of left to right shunt (Qp/Qs) ratio in children with Acyanotic congenital heart disease -A cross sectional study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056785
Enrollment
60
Registered
2023-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

Control Intervention1: Nil: Nil

Sponsors

Jawaharlal nehru medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All infant and children presenting with heart murmur, features of CCF, failure to thrive or history of recurrent respiratory infection, diagnosed to have ASD, VSD, PDA under echocardiography.

Exclusion criteria

Exclusion criteria: Children with: 1. Septic shock, Thrombocytopenia 2. Renal failure, Low GFR 3. Active NEC, Active bleeding, Intra cranial Hemorrhage 4. Heart failure due to cardiomyopathy, myocarditis, pericarditis or coronary artery disease.

Design outcomes

Primary

MeasureTime frame
To establish a relation between serum NT pro BNP levels & severity of shunt in patients of left to right shunt ASD VSD and PDA & other acyanotic conditions based on echocardiographic and hemodynamic evaluationsTimepoint: 1 year hospital based study—

Secondary

MeasureTime frame
To determine cutoff point for surgical intervention in such patientsTimepoint: 1 year hospital based study—

Countries

India

Contacts

Public ContactDr Ankit Anand

Jawaharlal Nehru medical College

manviveeresh@gmail.com9164000009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026